NENG LEE: Open Payments
NPI 1972511970 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 39 payments from 14 companies in 2025. Trend: 2023 $1,256 · 2024 $1,350 · 2025 $1,359
Food & beverage: $1,317Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $387 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $209 |
| Gilead Sciences, Inc. | 4 | $133 |
| Corcept Therapeutics | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Amgen Inc. | 2 | $46 |
| Mannkind Corporation | 1 | $43 |
| ABBVIE INC. | 1 | $29 |
Products named: AIRSUPRA, Kerendia, Korlym, Wegovy, JARDIANCE, OTEZLA, KEVEYIS, AFREZZA.
Industry payments across CA — which companies pay providers there.
